Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-25-020250·Cocrystal Pharma, Inc.
Schedule 13D ownership disclosure
COCRYSTAL PHARMA INC
Common Stock, par value $0.001 per share · CUSIP: 19188J409
Event date: 2025-10-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Phillip Frost, M.D.Reported CIK 0000898860
Shares: 2,462,012.00 · Class: 17.8%
- Frost Gamma Investments TrustReported CIK 0001380896
Shares: 2,398,977.00 · Class: 17.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-020250
- Form type
- SCHEDULE 13D/A
- Filer
- Cocrystal Pharma, Inc.
- CIK
- CIK 1412486
- Filed
- Oct 30, 2025
- Reporting period
- Oct 28, 2025
- Description
- Schedule 13D beneficial ownership